Globus Medical called a top small-cap pick for 2014 at Leerink Leerink calls Globus Medical a top small-cap pick for 2014 and raised its price target for shares to $26 from $22. The firm says Globus' valuation remains below peers despite the stock's 88% rise in 2013 and it reiterates an Outperform rating on the name.
News For GMED From The Last 14 Days
Check below for free stories on GMED the last two weeks.
Globus Medical downgraded to Hold from Buy at WallachBeth WallachBeth downgraded Globus Medical citing valuation but raised its price target for shares to $27 from $23 following the company's Q4 results.